Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Cue Biopharma, Inc. (CUE)

NASDAQ

$31,21

$--

(0,00%)

Pre-Market

Cue Biopharma, Inc. (CUE) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Cue Biopharma, Inc. (CUE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $31,21, with a market capitalisation of $221,93M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,97 to $45,50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$221,93M
Open	$31,21
Day's High	$950,70
Day's Low	$4,97
Previous Close	$31,64
Volume	62,00
Average Volume	161,99K
P/E Ratio	--
52-Week High	$45,50
52-Week Low	$4,97
Dividend Yield	--
Earnings Date	--

Cue Biopharma, Inc. (CUE) Pre-Market Stock Price

Cue Biopharma, Inc. (CUE) is trading at $31,21 in pre-market trading as of 2026-09-16 08:12:00, down 1,37% ($0,44) from the previous close of $31,64

Pre-market trading shows how investors are pricing CUE before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Cue Biopharma, Inc. (CUE) 7-Day Stock Price Change

Over the past seven days, Cue Biopharma, Inc. (CUE) moved from $27,44 to $31,21, representing a gain of 13,72% ($3,76).

The stock traded between $25,62 and $32,13 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 144,91 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CUE 52-Week Price Position

Position in Range: 64,7%

52W Low$4,97

52W High$45,50

CUE is currently trading at $31,21, placing it 64,7% of the way from its 52-week low of $4,97 to its 52-week high of $45,50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cue Biopharma, Inc. (CUE)?

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Cue Biopharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	29
Exchange	NASDAQ
Company Website	https://www.cuebiopharma.com

How to Buy Cue Biopharma, Inc. (CUE) Stock on MEXC

Eligible investors can buy real shares of Cue Biopharma, Inc. (CUE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CUE and Place Your Order

Open the RealStocks trading page and search for CUE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cue Biopharma, Inc. (CUE) stock price today?

Cue Biopharma, Inc. (CUE) is currently trading at $ 31,21, down 1,37% ($0,44) from the previous close of $ 31,64. Intraday prices update in real time during regular trading hours.

2.Is CUE stock going up or down today?

As of 2026-09-16 08:12:00, CUE is trading at $ 31,21, down 1,37% ($0,44) from its previous close of $ 31,64. The stock has traded between $ 4,97 and $ 950,70 during today’s regular session. Past price movements do not guarantee future results.

3.What is CUE pre-market price?

As of 2026-09-16 08:12:00, CUE is trading at $ 31,21 in pre-market trading, down 1,37% ($0,44) from the previous close of $ 31,64. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CUE after-hours price?

As of 2026-09-16 08:12:00, CUE is trading at $ 31,20 in after-hours trading, down 1,38% ($0,44) from the regular-session close of $ 31,64. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CUE stock trading now?

CUE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CUE sit relative to its 52-week high and low?

Over the past 52 weeks, CUE has traded between a low of $ 4,97 and a high of $ 45,50. At $ 31,21, the stock is positioned 64,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cue Biopharma, Inc. in?

Cue Biopharma, Inc. (CUE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cue Biopharma, Inc.'s market capitalisation and where is it listed?

Cue Biopharma, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 221,93M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CUE valued in terms of P/E ratio and EPS?

CUE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -22,59. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cue Biopharma, Inc. pay a dividend?

Cue Biopharma, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.